Latest News about GSK
Recent news which mentions GSK
From Benzinga
From Benzinga
Price Over Earnings Overview: GSK
August 27, 2025
From Benzinga
Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study
August 21, 2025
From Benzinga
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
August 21, 2025
From Benzinga
From Benzinga
Earnings Scheduled For July 30, 2025
July 30, 2025
From Benzinga
After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact
July 28, 2025
From Benzinga
From Benzinga
Tickers
GSK
From TalkMarkets
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons
July 02, 2025
From Benzinga
Price Over Earnings Overview: GSK
July 02, 2025
From Benzinga
GSK Rebranded Flovent Asthma Inahler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses
June 27, 2025
From Benzinga
AppLovin, First Solar And Li Auto Are Among Top 10 Large Cap Losers Last Week (June 16-20): Are The Others In Your Portfolio?
June 22, 2025
From Benzinga
FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag
June 20, 2025
From Benzinga
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
June 13, 2025
From Benzinga
From Wall Street Pit
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
June 09, 2025
From Benzinga
Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps
June 04, 2025
From Benzinga
Will European Stocks Eat The U.S. For Breakfast?
June 03, 2025
From TalkMarkets
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.